This possibility is confirmed by the recent observation that among patients with diabetic nephropathy, the presence of deposits of C3 activation products in kidney biopsy was associated with lower renal function and more severe tubular and glomerular damage (Sun et al., 2018). This evidence concerns the gene C3 and diabetic kidney disease.